M&A Deal Summary

Life Technologies Acquires BAC BV

On January 22, 2013, Life Technologies acquired life science company BAC BV from FPE Capital

Acquisition Highlights
  • This is Life Technologies’ 7th transaction in the Life Science sector.
  • This is Life Technologies’ 1st transaction in the Netherlands.

M&A Deal Summary

Date 2013-01-22
Target BAC BV
Sector Life Science
Buyer(s) Life Technologies
Sellers(s) FPE Capital
Deal Type Add-on Acquisition

Target

BAC BV

Naarden, Netherlands
BAC BV discovers, develops and manufactures separation and affinity purification products for use across the value chain of biopharmaceutical R&D and manufacturing.

Search 215,074 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Life Technologies

Carlsbad, California, United States

Category Company
Sector Test/Measurement Equipment
Employees10,000
Revenue 3.8B USD (2012)
DESCRIPTION

Life Technologies Corporation is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents and licenses that span the entire biological spectrum – scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research.


DEAL STATS #
Overall 16 of 16
Sector: Life Science M&A 7 of 7
Type: Add-on Acquisition M&A Deals 13 of 13
Country: Netherlands M&A 1 of 1
Year: 2013 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-08 Compendia Bioscience

Ann Arbor, Michigan, United States

Compendia Bioscience, Inc. is a preeminent cancer bioinformatics company widely used by the pharmaceutical industry to identify novel gene targets for drug discovery and development.

Buy -

Seller(S) 1

SELLER

FPE Capital

London, United Kingdom

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 2004
Size Small
Type Sector Agnostic
DESCRIPTION

FPE Capital is the private equity investment arm of Fleming Family & Partners, a multi-family office. FF&P invests in lower middle market companies throughout the UK and Western Europe. FF&P focuses on rapidly growing companies led by experienced management, with proven track records and scalable business models. Sectors of interest include financial services, healthcare, business/support services, energy/resources and media/information. The Firm will consider buyouts (MBOs, MBIs) as well as growth capital financings. FPE Capital was formed in 2004 and is based in London.


DEAL STATS #
Overall 9 of 24
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 3 of 10
Country: Netherlands M&A 1 of 1
Year: 2013 M&A 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-11 Harvest Media Group

London, United Kingdom

Harvest Media Group is a provider of interactive services to media and corporate clients to build direct relationships with their consumers in the United Kingdom.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-12 Fevertree Drinks

London, United Kingdom

Fevertree Drinks is a manufacturer and supplier of premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. Fevertree Drinks was founded in 2013 and is based in London, England.

Sell £48M